Results for intweriet translation from Maltese to English

distribuzzjoni fil-fluwidu ċerebrospinali intweriet.
distribution into the cerebrospinal fluid has been demonstrated.

adulti b’ rosacea tal- wiċċ intweriet biżżejjed,
facial rosacea to be sufficiently demonstrated,

is- sigurtà tal- prodott intweriet b' mod sodisfaċenti.
safety of the product was satisfactorily demonstrated.

intweriet riversibbiltà tal-effetti fuq iċ-ċiklu tal-mestrwazzjoni.
reversibility of the effects on menstrual cycle length was demonstrated.

intweriet stabbilità kimika u fiżika għal 4 sigħat f’ 25°c.
chemical and physical in-use stability has been demonstrated for 4 hours at 25°c.

wara li jkun rikostitwit, l-istabbilità kimika u fiżika intweriet għal 6 sigħat.
once reconstituted, chemical and physical stability has been demonstrated for 6 hours.

attività kontra t-tumur intweriet primarjament f’pazjenti b’newroblastoma.
antitumour activity was demonstrated primarily in patients with neuroblastoma.

is-sigurtà ta’ ig 10% intweriet f’diversi studji mhux kliniċi.
the safety of ig 10% has been demonstrated in several non-clinical studies.

f’dawn il-pazjenti, doża ta’ 45 mg ukoll intweriet li kienet effettiva.
in these patients, 45 mg was also shown to be efficacious.

għalhekk, l-effikaċja ta’ ratiograstim intweriet bħala ekwivalenti għal dik ta’ neupogen.
therefore, the effectiveness of ratiograstim was shown to be equivalent to that of neupogen.

l- istabilità kimika u fiżika waqt l- użu intweriet għal 27 jum f’ 2ºc – 8ºc.
chemical and physical in-use stability has been demonstrated for 27 days at 2ºc – 8ºc.

id-doża l-baxxa ta’ gilenya intweriet li kienet effettiva daqs l-ogħla doża.
the lower dose of gilenya was shown to be as effective as the higher dose.

intweriet ukoll kardjotossiċità minima b’pixuvri b’ċikli ta’ kura ripetuti fl-istess dożi.
minimal cardiotoxicity of pixuvri was also demonstrated with repeat treatment cycles at the same doses.

f’dan l- istudju, protezzjoni li sservi għal żmien twil intweriet b’mod statistiku għal madwar 8 snin.
in this study, a durable protection was statistically demonstrated to approximately 8 years.

intweriet effikaċja bħala trattament monoterapewtiku tal- kriżi ta 'assenza tipika (typical absence seizures).
efficacy as monotherapy treatment of typical absence seizures was demonstrated.

madankollu, stabbiltà waqt l-użu intweriet għal tliet sigħat f’temperatura ta’ 2-8 °c.
however, the in-use stability has been demonstrated for 3 hours at 2-8 °c.

għalkemm mhuwiex irrakkomandat dewmien, intweriet stabbilità għal 8 sigħat f’temperatura ta’ 30°c wara r-rikostituzzjoni.
although delay is not recommended, stability has been demonstrated for 8 hours at 30°c after reconstitution.

is-sigurtà ta’ rhiniseng intweriet f’diversi studji tal-laboratorju u fil-qasam immexxijin u rrapportati tajjeb.
the safety of rhiniseng was demonstrated in several well conducted and reported laboratory and field studies.

madankollu, intweriet stabbilità fl-użu ta’ tlett sigħat f’temperatura ta’ 2°c - 8°c.
however, in-use stability has been demonstrated for 3 hours at 2°c - 8°c.

intweriet effikaċja fil-pressjoni għolja primarja tal-pulmun u fil-pressjoni għolja fil- pulmun assoċjata ma’ mard tat-tessut konnettiv.
efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.